Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.826
Neutral
RSI(14)
41.727
Neutral
STOCH(KDJ)(9,3,3)
37.723
Sell
ATR(14)
6.775
Low Volatility
CCI(14)
-45.945
Neutral
Williams %R
68.786
Sell
TRIX(12,20)
-0.127
Sell
StochRSI(14)
1.269
Oversold
Search
Veeva Systems Inc
VEEVAdd to Watchlist
154.530USD
-4.890-3.07%
Market hours （ET）Quotes delayed by 15 min
25.31BMarket Cap
27.83P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Veeva Systems Inc
Currency: USD Updated: 2026-05-12Key Insights
Veeva Systems Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 36 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 268.36.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Veeva Systems Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
Veeva Systems Inc Highlights
StrengthsRisks
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 35.18% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 3.20B.
Undervalued
The company’s latest PE is 28.71, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 147.70M shares, decreasing 3.13% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 2.05K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 1.89.
Analyst Rating
Based on
30
analysts
Buy
Current Rating
268.364
Target Price
+61.33%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-12The current financial score of Veeva Systems Inc is 7.64, ranking 60 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 835.95M, representing a year-over-year increase of 15.96%, while its net profit experienced a year-over-year increase of 24.83%.
Score
Financials
10.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.67
Operational Efficiency
6.99
Growth Potential
7.67
Shareholder Returns
6.87
Veeva Systems Inc's Company Valuation
Currency: USD Updated: 2026-05-12The current valuation score of Veeva Systems Inc is 6.40, ranking 159 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 28.71, which is 160.70% below the recent high of 74.84 and 5.01% above the recent low of 27.27.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 36/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-12The current earnings forecast score of Veeva Systems Inc is 7.94, ranking 111 out of 206 in the Healthcare Equipment & Supplies industry. The average price target is 320.00, with a high of 380.00 and a low of 222.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
30
analysts
Buy
Current Rating
268.364
Target Price
+61.33%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Veeva Systems Inc
VEEV
30
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
31
Waters Corp
WAT
25
1
2
3
...
19
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-12The current price momentum score of Veeva Systems Inc is 6.97, ranking 84 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 172.25 and the support level at 149.44, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
164.138
Sell
MA10
164.789
Sell
MA20
164.373
Sell
MA50
172.851
Sell
MA100
189.833
Sell
MA200
233.318
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-12The current institutional shareholding score of Veeva Systems Inc is 10.00, ranking 1 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 90.50%, representing a quarter-over-quarter increase of 1.20%. The largest institutional shareholder is Chase Coleman, holding a total of 2.42M shares, representing 1.48% of shares outstanding, with 0.14% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-12The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Veeva Systems Inc is 7.27, ranking 43 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 0.93. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.93
VaR
+3.32%
240-Day Maximum Drawdown
+50.55%
240-Day Volatility
+41.20%
Return
Best Daily Return
60 days
+10.02%
120 days
+10.02%
5 years
+19.67%
Worst Daily Return
60 days
-5.70%
120 days
-9.77%
5 years
-16.24%
Sharpe Ratio
60 days
-0.54
120 days
-2.89
5 years
-0.21
Risk Assessment
Maximum Drawdown
240 days
+50.55%
3 years
+50.55%
5 years
+55.69%
Return-to-Drawdown Ratio
240 days
-0.63
3 years
-0.12
5 years
-0.19
Skewness
240 days
+1.81
3 years
+0.63
5 years
+0.61
Volatility
Realised Volatility
240 days
+41.20%
5 years
+38.97%
Standardised True Range
240 days
+4.64%
5 years
+4.08%
Downside Risk-Adjusted Return
120 days
-399.06%
240 days
-399.06%
Maximum Daily Upside Volatility
60 days
+37.02%
Maximum Daily Downside Volatility
60 days
+35.98%
Liquidity
Average Turnover Rate
60 days
+1.78%
120 days
+1.49%
5 years
--
Turnover Deviation
20 days
+189.12%
60 days
+95.75%
120 days
+63.52%
Peer Comparison
Healthcare Equipment & Supplies
Veeva Systems Inc
VEEV
7.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.76 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.57 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.42 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.30 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
